Post-earnings recap
Reported
Thu, Feb 27, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a loss per share of $0.07, significantly missing expectations. The stock reacted negatively, declining by 3.94%. The lack of revenue data and management commentary leaves investors with limited insight into future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.07 | N/A | -149.71% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.